MedPath

GRUPO DE ESTUDOS MULTICENTRICOS EM ONCO-HEMATOLOGIA

🇧🇷Brazil
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:3

Trial Phases

2 Phases

Phase 3:5
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 3
5 (83.3%)
Phase 4
1 (16.7%)

Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation

Phase 3
Conditions
Multiple Myeloma Stage I
First Posted Date
2019-01-03
Last Posted Date
2019-01-03
Lead Sponsor
Grupo de Estudos Multicentricos em Onco-Hematologia
Target Recruit Count
20
Registration Number
NCT03792620
Locations
🇧🇷

CEHON - Centro de Hematologia e Oncologia da Bahia, Salvador, Bahia, Brazil

Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

Phase 3
Completed
Conditions
Multiple Myeloma
Effects of Chemotherapy
Interventions
First Posted Date
2018-01-18
Last Posted Date
2018-01-18
Lead Sponsor
Grupo de Estudos Multicentricos em Onco-Hematologia
Target Recruit Count
311
Registration Number
NCT03402295

T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients

Conditions
T-cell Lymphoma
T-cell Lymphoma Adults
NK-Cell Lymphoma
First Posted Date
2017-07-05
Last Posted Date
2017-07-05
Lead Sponsor
Grupo de Estudos Multicentricos em Onco-Hematologia
Target Recruit Count
500
Registration Number
NCT03207789

Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients

Phase 4
Conditions
Oral Hemorrhage
Interventions
First Posted Date
2014-09-12
Last Posted Date
2014-09-12
Lead Sponsor
Grupo de Estudos Multicentricos em Onco-Hematologia
Target Recruit Count
154
Registration Number
NCT02238288
Locations
🇧🇷

Clementino Fraga Filho University Hospital, Rio de Janeiro, RJ, Brazil

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Phase 3
Completed
Conditions
Graft vs Host Disease
Oral Manifestations
Interventions
First Posted Date
2012-10-03
Last Posted Date
2012-10-03
Lead Sponsor
Grupo de Estudos Multicentricos em Onco-Hematologia
Target Recruit Count
28
Registration Number
NCT01699412
Locations
🇧🇷

Hematology and Hemotherapy Center, Campinas, São Paulo, Brazil

🇧🇷

Clementino Fraga Filho University Hospital, Rio de Janeiro, Brazil

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath